ScoreHaematology
Outpatient Bleeding Risk Index (OBRI)
Predicts the risk of major bleeding in outpatients starting warfarin.
Updated 30 October 2026
When to use it
When starting oral anticoagulation with vitamin K antagonists in outpatients, whatever the indication.
What it needs
- Age ≥ 65 years
- History of stroke
- History of gastrointestinal bleeding
- Comorbidity (scores 1 point if at least one is present)
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 0 | Low risk (major bleeding ≈ 3 % at 48 months) |
| 1–2 | Intermediate risk (≈ 12 % at 48 months) |
| ≥ 3 | High risk (≈ 53 % at 48 months) |
Practical tip
The comorbidity group adds at most 1 point, even if the patient has several of those conditions.
2 more practical tips in the app.
Reference
- Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105(2):91-99.
- Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87(2):144-152.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
